TuHURA Biosciences (HURA) Change in Accured Expenses (2012 - 2026)

TuHURA Biosciences' Change in Accured Expenses history runs 15 years deep, the most recent figure standing at $452006.0 for Q1 2026.

• In Q1 2026, Change in Accured Expenses rose 1.45% year-over-year to $452006.0; the TTM figure through Mar 2026 stood at -$3.8 million (down 1605.86% YoY), while the FY2025 annual figure was -$3.8 million, down 203.19% from the prior year.
• Change in Accured Expenses for Q1 2026 stood at $452006.0, up from $150447.0 in the prior quarter.
• The five-year high for Change in Accured Expenses was $1.9 million in Q2 2025, with the low at -$6.2 million in Q3 2025.
• The 5-year median for Change in Accured Expenses is -$113000.0 (2022), against an average of -$473455.1.
• The sharpest annual moves came in 2024 and 2025: Change in Accured Expenses tumbled 1802.47% in 2024, then jumped 605.99% in 2025.
• TuHURA Biosciences' Change in Accured Expenses stood at -$749000.0 in 2022, then tumbled by 41.79% to -$1.1 million in 2023, then jumped by 216.98% to $1.2 million in 2024, then sank by 87.89% to $150447.0 in 2025, then soared by 200.44% to $452006.0 in 2026.
• Business Quant data shows HURA's Change in Accured Expenses at $452006.0 in Q1 2026, $150447.0 in Q4 2025, and -$6.2 million in Q3 2025.